Renalytix (Renalytix) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Renalytix ROE % Adjusted to Book Value?

Renalytix's ROE % for the quarter that ended in Mar. 2024 was 0.00%. Renalytix's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Renalytix's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

Renalytix ROE % Adjusted to Book Value Historical Data

The historical data trend for Renalytix's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix ROE % Adjusted to Book Value Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-53.22

-3.96

-4.08

-15.04

-17.78

Renalytix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-41.26	-25.96	-	-1,087.96	-

Competitive Comparison of Renalytix's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Renalytix's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Renalytix's ROE % Adjusted to Book Value falls into.

Renalytix ROE % Adjusted to Book Value Calculation

Renalytix's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-242.76%	/	13.65
	=	-17.78%

Renalytix's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Renalytix ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Renalytix's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (Renalytix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

RNLX:USA RENX:UK 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.